Rasburicase in treating tumor lysis syndrome: An umbrella review.

Mahfooz K, Sohail H, Gvajaia A, Arif U, Grewal D, Muppidi MR, Vohra V, Tarique A, Vasavada A.

Open source

DOI
10.1016/j.cpt.2023.07.001
Published
2023-07-20
Container
Cancer Pathog Ther
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.cpt.2023.07.001,
  title = {Rasburicase in treating tumor lysis syndrome: An umbrella review.},
  author = {Mahfooz K and  Sohail H and  Gvajaia A and  Arif U and  Grewal D and  Muppidi MR and  Vohra V and  Tarique A and  Vasavada A.},
  year = {2023},
  journal = {Cancer Pathog Ther},
  doi = {10.1016/j.cpt.2023.07.001},
  url = {https://doi.org/10.1016/j.cpt.2023.07.001}
}

RIS

TY  - JOUR
TI  - Rasburicase in treating tumor lysis syndrome: An umbrella review.
AU  - Mahfooz K
AU  -  Sohail H
AU  -  Gvajaia A
AU  -  Arif U
AU  -  Grewal D
AU  -  Muppidi MR
AU  -  Vohra V
AU  -  Tarique A
AU  -  Vasavada A.
PY  - 2023
JO  - Cancer Pathog Ther
DO  - 10.1016/j.cpt.2023.07.001
UR  - https://doi.org/10.1016/j.cpt.2023.07.001
ER  -

APA

K, M., H, S., A, G., U, A., D, G., MR, M., V, V., A, T., & A., V. (2023). Rasburicase in treating tumor lysis syndrome: An umbrella review.. Cancer Pathog Ther. https://doi.org/10.1016/j.cpt.2023.07.001

Source records